Xbiotech Inc (XBIT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -37,483 | -25,594 | -14,858 | -8,114 | -21,720 |
| Depreciation Amortization | 699 | 510 | 341 | 165 | 660 |
| Accounts payable and accrued liabilities | 840 | 1,124 | 144 | 883 | 1,068 |
| Other Working Capital | -774 | -884 | -3,346 | 196 | 2,340 |
| Other Operating Activity | 3,410 | 2,231 | 2,325 | 339 | 5,952 |
| Operating Cash Flow | $-33,308 | $-22,613 | $-15,394 | $-6,531 | $-11,700 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -10,392 | -6,646 | -2,210 | -571 | -1,390 |
| Investing Cash Flow | $-10,392 | $-6,646 | $-2,210 | $-571 | $-1,390 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 77,060 | 76,733 | 76,703 | 2,409 | 63,524 |
| Other Financing Activity | 410 | 735 | 735 | -302 | -324 |
| Financing Cash Flow | $77,470 | $77,468 | $77,438 | $2,107 | $63,200 |
| Exchange Rate Effect | -48 | 142 | 219 | -98 | -10 |
| Beginning Cash Position | 57,329 | 57,329 | 57,329 | 57,329 | 7,240 |
| End Cash Position | 91,051 | 105,680 | 117,382 | 52,236 | 57,320 |
| Net Cash Flow | $33,722 | $48,351 | $60,053 | $-5,093 | $50,080 |
| Free Cash Flow | |||||
| Operating Cash Flow | -33,308 | -22,613 | -15,394 | -6,531 | -11,700 |
| Capital Expenditure | -10,392 | -6,646 | -2,210 | -571 | -1,397 |
| Free Cash Flow | -43,700 | -29,259 | -17,604 | -7,102 | -13,097 |